Target, Home Depot,...
Health Care: Drugs
Pacira Pharmaceuticals Inc. (PCRX: NASDAQ)
$29.44 0.27 | 0.93%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 10.13M | 46.17M | 26.13M | 7.08M |
| Receivables | 4.35M | 2.11M | 1.19M | 1.46M |
| Inventories | 12.08M | 1.24M | 1.60M | 1.73M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 60.92M | 82.65M | 31.06M | 12.55M |
| Property, Plant & Equipment, Gross | 50.72M | 33.38M | 30.02M | 24.15M |
| Accumulated Depreciation & Depletion | 11.60M | 8.28M | 6.07M | 4.59M |
| Property, Plant & Equipment, Net | 39.12M | 25.10M | 23.95M | 19.56M |
| Intangibles | 3.21M | 5.26M | 8.91M | 11.18M |
| Other Non-Current Assets | 511.00K | 479.00K | 2.64M | 667.00K |
| Total Non-Current Assets | 51.13M | 30.84M | 35.51M | 31.40M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 112.05M | 113.49M | 66.56M | 43.95M |
| Accounts Payable | 2.57M | 3.44M | 6.04M | 6.99M |
| Short Term Debt | 823.00K | 8.26M | 3.18M | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 1.58M | 1.60M |
| Total Current Liabilities | 14.16M | 31.91M | 16.32M | 14.42M |
| Long Term Debt | 25.19M | 18.54M | 21.87M | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 6.00M | 13.24M | 76.75M | 52.49M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 32.04M | 33.31M | 98.62M | 52.49M |
| Total Liabilities | 46.20M | 65.22M | 114.94M | 66.90M |
| Preferred Stock Equity | 0.00 | 0.00 | 6.00K | 6.00K |
| Common Stock Equity | 65.86M | 48.27M | -48.39M | -22.96M |
| Common Par | 33.00K | 25.00K | 1.00K | 1.00K |
| Additional Paid In Capital | 298.32M | 228.47M | 88.52M | 86.81M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -232.52M | -180.24M | -136.91M | -109.76M |
| Treasury Stock | -2.00K | -2.00K | -2.00K | 0.00 |
| Other Equity Adjustments | 27.00K | 15.00K | 0.00 | 0.00 |
| Total Capitalization | 91.05M | 66.81M | -26.51M | -22.95M |
| Total Equity | 65.86M | 48.27M | -48.38M | -22.95M |
| Total Liabilities & Stock Equity | 112.05M | 113.49M | 66.56M | 43.95M |
| Total Common Shares Outstanding | 32.62M | 25.34M | 17.23M | 17.23M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 1.06K | 1.06K | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 30.33M | 16.44M | 574.07K | 573.12K |
| Diluted Weighted Shares Outstanding | 30.33M | 16.44M | 574.07K | 573.12K |
| Number of Employees | 133 | 131 | 83 | 83 |
| Number of Part-Time Employees | 0 | 2 | 0 | 0 |
Portfolios with PCRX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- UserNew
- ContributorUnder-$10 Setting Up To Tra...
- UserDayTrading Test 1
- Contributor10 Best-Performing IPOs of ...
- Contributor10 Health-Care Stocks Outpe...
Latest PCRX Headlines from TheStreet
- TheStreet Ratings Top 10 Rating Changes 05.13.13 | 01:05 pm
- SALT 2013: The 5 Best Ideas of the Year Ahead 05.10.13 | 04:05 pm
- Pacira Pharmaceuticals Inc. Stock Downgraded (PCRX) 05.10.13 | 05:05 am
- Top Insider Trades: AGCO ECHO PCRX TWER 03.26.13 | 04:03 pm
- Top Insider Trades: CHDN, PCRX, ULTA, PMBC 03.22.13 | 08:03 am
- 'Mad Money' Lightning Round: Stick With Cummins, Sell Micron 03.14.13 | 06:03 am
- Cramer's 'Mad Money' Recap: A Resting Bull Market 03.13.13 | 07:03 pm
- Pacira Pharmaceuticals Inc. Stock Upgraded (PCRX) 03.11.13 | 05:03 am
- 4 Stocks Rising on Unusual Volume 02.01.13 | 03:02 pm
- Top Insider Trades: BAC LGND PCRX BDBD 01.28.13 | 08:01 am
Press Releases for PCRX
- Analysis Of Postsurgical Pain Management Finds Opioid-Related Adverse Events Drive Longer Hospital Stays, Greater Cost And Higher Likelihood Of Readmission - Business Wire 03.27.13 | 06:03 am
- Pacira Pharmaceuticals, Inc. To Present At The Barclays Global Healthcare Conference - Business Wire 03.06.13 | 06:03 am
- Pacira Pharmaceuticals, Inc. Announces Timing For 2012 Financial Results Webcast And Conference Call - Business Wire 02.28.13 | 06:02 am
- Pacira Pharmaceuticals, Inc. To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.25.13 | 06:02 am
- Pacira Pharmaceuticals, Inc. Announces Pricing Of $110 Million Private Offering Of Convertible Senior Notes - Business Wire 01.17.13 | 08:01 am
- Pacira Pharmaceuticals, Inc. Announces Proposed Offering Of $100 Million Of Convertible Senior Notes - Business Wire 01.15.13 | 04:01 pm
- New Publication Suggests Higher Opioid Use In The Postsurgical Setting May Be Linked To Extended Hospital Stay And Increased Cost Of Care - Business Wire 12.18.12 | 06:12 am
- Http://www.aratanatherapeutics.com/ - Business Wire 12.06.12 | 06:12 am
- Pacira Pharmaceuticals, Inc. To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.20.12 | 06:11 am
- New Data Demonstrate Reduction In Opioid Use, Hospital Cost And Length Of Stay With EXPAREL As The Foundation Of A Multimodal Regimen - Business Wire 11.20.12 | 06:11 am
Partner Headlines for PCRX
- UPDATE: Wedbush Raises PT to $32 on Pacira Pharmaceuticals on Long-Term Outlook - Benzinga 03.07.13 | 01:03 pm
- 3 Outperforming Small Caps Bought Up By Insiders And Hedge Funds - Seeking Alpha 04.13.12 | 07:04 pm
- Noteworthy Insider Buys In The Healthcare Sector Last Week - Seeking Alpha 11.29.11 | 08:11 am
- How Will Congress' Budget Cuts Affect Health Care? - Benzinga 11.21.11 | 01:11 pm
- Decision Due For Pacira's Flagship Drug EXPAREL - Seeking Alpha 10.31.11 | 08:10 am
- Biotech Catalysts for Third Quarter - Seeking Alpha 06.24.11 | 06:06 pm
- 6 Stocks With Recent CFO Buys - Seeking Alpha 02.25.11 | 08:02 am
- 7 Diverse U.S. IPOs Test Investor Appetites This Week - Seeking Alpha 02.13.11 | 06:02 am
- RPT-IPO VIEW-Biotech IPO spurt to test U.S. market - Reuters 02.06.11 | 10:02 am
- IPO VIEW-Biotech IPO spurt to test U.S. market - Reuters 02.04.11 | 07:02 pm
